Clinical trial Recruiting at 1 site Observational Ages 18 and up

Cutibacterium acnes and degenerative lumbar disc disease after microdiscectomy

Official title: The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease and the Clinical Effect of Microdiscectomy

Run by Masaryk University · NCT07085247 · Data updated 2026-11-12

This project will try to see if the bacterium Cutibacterium acnes is linked to degenerative lumbar disc disease in adults who had microdiscectomy for lumbar disc herniation.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorMasaryk University
Academic / other
Locations1 site (Brno)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJune 30, 2028
Study endsDecember 31, 2028
Registry record updatedAugust 27, 2025
Trial IDNCT07085247 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with MRI-confirmed lumbar disc protrusion/herniation or sequestration, matching clinical exam findings, and who are scheduled for microdiscectomy without recent antibiotic or corticosteroid use are ideal candidates.

Probably not a fit

Patients without MRI-confirmed herniation, those with non-surgical causes of low back pain, immunocompromised individuals, recent antibiotic/corticosteroid users, or those with inflammatory/rheumatologic spine disease are unlikely to receive direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project combines a retrospective analysis of an existing database of roughly 1,200 adults treated for symptomatic lumbar disc herniation at St. Anne's University Hospital Brno, of which at least 400 have complete epidemiologic, MRI, microbiological, and clinical records. The prospective arm will enroll new patients scheduled for microdiscectomy, collect preoperative clinical data, obtain perioperative disc tissue samples, perform microbiological testing for Cutibacterium acnes, and conduct postoperative follow-up visits. Microbiological findings will be correlated with imaging and standardized clinical outcomes and analyzed with appropriate data management and statistical methods. Comparisons between retrospective and prospective cohorts will be used to clarify whether the bacterium is associated with degenerative lumbar intervertebral disc disease.

Why it matters

Potential benefit: If successful, this work could show a bacterial contribution to disc degeneration and point toward new prevention or treatment approaches that reduce back pain and improve surgical outcomes.

How similar studies have gone: Previous studies have suggested a possible link between low-virulence Cutibacterium acnes in disc tissue and disc degeneration, but results have been mixed and the relationship remains controversial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* minimum age of 18 years
* MRI of the lumbosacral spine performed one month ± 2weeks before surgery showing a disc protrusion, herniation, or free nucleus pulposus sequestration
* matching physical examination findings including positive straight leg raise test, dermatomal sensory deficits, myotome motor deficits, and diminished deep tendon reflexes.

Exclusion Criteria:

* antibiotics or corticosteroid use the month before surgery
* ongoing bacterial or viral infection
* immunocompromised patient
* trauma
* undefined radiological mass
* inflammatory arthritis
* other rheumatologic diseases.

Where it's running

  • St. Anne´s University Hospital Brno
    Brno, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.